Search

Your search keyword '"Marjolein van Egmond"' showing total 131 results

Search Constraints

Start Over You searched for: Author "Marjolein van Egmond" Remove constraint Author: "Marjolein van Egmond"
131 results on '"Marjolein van Egmond"'

Search Results

1. Intrathecal IgG and IgM synthesis correlates with neurodegeneration markers and corresponds to meningeal B cell presence in MS

2. Antagonizing FcαR1 (CD89) as treatment in IgA-mediated chronic inflammation and autoimmunity

3. Enhanced IgA coating of bacteria in women with Lactobacillus crispatus-dominated vaginal microbiota

4. Anti-FcαRI Monoclonal Antibodies Resolve IgA Autoantibody-Mediated Disease

5. Fibrodysplasia Ossificans Progressiva: What Have We Achieved and Where Are We Now? Follow-up to the 2015 Lorentz Workshop

6. Clickable Vitamins as a New Tool to Track Vitamin A and Retinoic Acid in Immune Cells

7. IgA Immune Complexes Induce Osteoclast-Mediated Bone Resorption

8. A Window of Opportunity: Targeting Cancer Endothelium to Enhance Immunotherapy

9. Oral Antibiotic Prophylaxis Reduces Surgical Site Infection and Anastomotic Leakage in Patients Undergoing Colorectal Cancer Surgery

10. IgA and FcαRI: Pathological Roles and Therapeutic Opportunities

11. Surgery for Colorectal Cancer: A Trigger for Liver Metastases Development? New Insights into the Underlying Mechanisms

12. FcγRIIIb Restricts Antibody-Dependent Destruction of Cancer Cells by Human Neutrophils

13. Spillage of bacterial products during colon surgery increases the risk of liver metastases development in a rat colon carcinoma model.

14. Human IgG3 with extended half-life does not improve Fc-gamma receptor-mediated cancer antibody therapies in mice.

15. The Role of Macrophages in Tumor Development

16. Anti-CD20 IgA can protect mice against lymphoma development: evaluation of the direct impact of IgA and cytotoxic effector recruitment on CD20 target cells

17. The importance of human FcgammaRI in mediating protection to malaria.

19. Supplemental Movie 2 from Antibody-Dependent Phagocytosis of Tumor Cells by Macrophages: A Potent Effector Mechanism of Monoclonal Antibody Therapy of Cancer

20. Supplemental Movie 1 from Antibody-Dependent Phagocytosis of Tumor Cells by Macrophages: A Potent Effector Mechanism of Monoclonal Antibody Therapy of Cancer

21. Detection of Circulating Tumor Cells Using the Attune NxT

23. The present and future of immunocytokines for cancer treatment

24. Mechanisms of colorectal liver metastasis development

25. Fcα Receptor-1-Activated Monocytes Promote B Lymphocyte Migration and IgA Isotype Switching

26. Targeting myeloid cells with bispecific antibodies as novel immunotherapies of cancer

27. Targeting the CD47-SIRPα Innate Immune Checkpoint to Potentiate Antibody Therapy in Cancer by Neutrophils

28. IgA and FcαRI: Versatile Players in Homeostasis, Infection, and Autoimmunity

30. Epidermal Growth Factor Receptor as Target for Perioperative Elimination of Circulating Colorectal Cancer Cells

31. Neutrophils as immune effector cells in antibody therapy in cancer

32. Therapeutic exploitation of neutrophils to fight cancer

33. NK cell-dependent antibody-mediated immunotherapy is improved in vitro and in vivo when combined with agonists for toll-like receptor 2 in head and neck cancer models

34. The role of retinoic acid in the production of immunoglobulin A

35. Augmented antibody-based anticancer therapeutics boost neutrophil cytotoxicity

36. CD62L Is a Functional and Phenotypic Marker for Circulating Innate Lymphoid Cell Precursors

37. New insights in the pathogenesis of immunoglobulin A vasculitis (Henoch-Schönlein purpura)

38. Mesangial deposition can strongly involve innate-like iga molecules lacking affinity maturation

39. Efficient Innate Immune Killing of Cancer Cells Triggered by Cell-Surface Anchoring of Multivalent Antibody-Recruiting Polymers

40. Afucosylated IgG Targets FcγRIV for Enhanced Tumor Therapy in Mice

41. Healthy human second-trimester fetal skin is deficient in leukocytes and associated homing chemokines

42. Fc gamma receptor IIa suppresses type I and III interferon production by human myeloid immune cells

43. Cross-talk between pathogen recognizing Toll-like receptors and immunoglobulin Fc receptors in immunity

44. The era of the immunoglobulin A Fc receptor FcRI; its function and potential as target in disease

45. Granulocytes as modulators of dendritic cell function

47. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

48. IgA Enhances NETosis and Release of Neutrophil Extracellular Traps by Polymorphonuclear Cells via Fc alpha Receptor I

49. Myeloid cells as effector cells for monoclonal antibody therapy of cancer

50. Detrimental dermal wound healing: What can we learn from the oral mucosa?

Catalog

Books, media, physical & digital resources